Accelerated diffusion and relaxation-diffusion MRI using time-division multiplexing EPI.

Purpose: To develop a time-division multiplexing echo-planar imaging (TDM-EPI) sequence for approximately two- to threefold acceleration when acquiring joint relaxation-diffusion MRI data with multiple TEs.

Methods: The proposed TDM-EPI sequence interleaves excitation and data collection for up to 3 separate slices at different TEs and uses echo-shifting gradients to disentangle the overlapping echo signals during the readout period. By properly arranging the sequence event blocks for each slice and adjusting the echo-shifting gradients, diffusion-weighted images from separate slices can be acquired. Therefore, we present 2 variants of the sequence. A single-TE TDM-EPI is presented to demonstrate the concept. Next, a multi-TE TDM-EPI is presented to highlight the advantages of the TDM approach for relaxation-diffusion imaging. These sequences were evaluated on a 3 Tesla scanner with a water phantom and in vivo human brain data.

Results: The single-TE TDM-EPI sequence can simultaneously acquire 2 slices with a maximum b value of 3000 s/mm and 2.5 mm isotropic resolution using interleaved readout windows with TE ≈ 78 ms. With the same b value and resolution, the multi-TE TDM-EPI sequence can simultaneously acquire 2 or 3 separate slices using interleaved readout sections with shortest TE ≈ 70 ms and ΔTE ≈ 30 ms. Phantom and in vivo experiments have shown that the proposed TDM-EPI sequences can provide similar image quality and diffusion measures as conventional EPI readouts with multiple echoes but can reduce the overall relaxation-diffusion protocol scan time by approximately two- to threefold.

Conclusion: TDM-EPI is a novel approach to acquire diffusion imaging data at multiple TEs. This enables a significant reduction in acquisition time for relaxation-diffusion MRI experiments but without compromising image quality and diffusion measurements, thus removing a significant barrier to the adoption of relaxation-diffusion MRI in clinical research studies of neurological and mental disorders.